SCHEMBL7736104

SCHEMBL7736104

COc1cc(OC)c(C(=O)[PH](=O)c2c(C)ccc(C(=O)c3ccccc3)c2C)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.44
HTT P42858 4/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPK1 P28482 3/20 0.44
HPGD P15428 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C19 P33261 2/20 0.44
PGR P06401 1/20 0.44
CYP2D6 P10635 1/20 0.44
SLC6A2 P23975 1/20 0.44
PDE4A P27815 1/20 0.44
HRH1 P35367 1/20 0.44
SLC6A3 Q01959 1/20 0.44
PDE4D Q08499 1/20 0.44
MAPT P10636 9/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 2/20 0.43
POLB P06746 1/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177385 0.90 MAPT (0.45) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7189930 0.89 MAPT (0.41) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7178047 0.86 MAPT (0.38) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7179380 0.85 MAPT (0.40) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7179738 0.83 HPGD (0.41) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7185352 0.83 MAPT (0.39) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7175667 0.83 MAPT (0.41) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7175461 0.82 MAPT (0.45) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7188161 0.82 MAPT (0.43) LMNAHTTALDH1A1MAPK1HPGD
SCHEMBL7185476 0.81 LMNA (0.43) LMNAHTTALDH1A1MAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 LMNA 3247/4885HTT 2393/4885ALDH1A1 3984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.